Dr. Daohong Zhou receives National Cancer Institute R01 grant
Daohong Zhou, M.D., a professor of pharmacodynamics, has received multiple recent grants, including a multiple principal investigator R01 from the National Cancer Institute, alongside his longtime collaborator Guangrong Zheng, Ph.D., an associate professor of medicinal chemistry Dr. Daohong Zhou The grant titled “Inhibition of Bcl-xL by Targeted Degradation” will carry…